Influence of glyco-oxidation on complexes between fibrin(ogen) and insulin-like growth factor-binding protein-1 in patients with diabetes mellitus type 2

References

• Vazzana N, Ranalli P, Cuccurullo C, Davì G. Diabetes mellitus and thrombosis. Thromb Res 2012;129:371–377.
   PubMed Web of Science ®Google Scholar
• Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol 2014;18:1–14.
   PubMed Web of Science ®Google Scholar
• Yonekura H, Yamamoto Y, Sakurai S, Watanabe T, Yamamoto H. Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury. J Pharmacol Sci 2005;97:305–311.
   PubMed Web of Science ®Google Scholar
• Pieters M, van Zyl DG, Rheeder P, Jerling JC, Loots DT, van der Westhuizen FH, et al. Glycation of fibrinogen in uncontrolled diabetic patients and the effects of glycaemic control on fibrinogen glycation. Thromb Res 2007;120:439–446.
   PubMed Web of Science ®Google Scholar
• Becatti M, Marcucci R, Bruschi G, Taddei N, Bani D, Gori AM, et al. Oxidative modification of fibrinogen is associated with altered function and structure in the subacute phase of myocardial infarction. Arterioscler Thromb Vasc Biol 2014;34:1355–1361.
   PubMed Web of Science ®Google Scholar
• Lee Y, Shacter E. Role of carbohydrates in oxidative modification of fibrinogen and other plasma proteins. Arch Biochem Biophys 1995;321:175–181.
   PubMed Web of Science ®Google Scholar
• Dunn EJ, Philippou H, Ariëns RAS, Grant PJ. Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus. Diabetologia 2006;49:1071–1080.
   PubMed Web of Science ®Google Scholar
• Carr ME. Diabetes mellitus: a hypercoagulable state. J Diabetes Complications 2001;15:44–54.
   PubMed Web of Science ®Google Scholar
• Campbell PG, Durham SK, Hayes JD, Suwanichkul A, Powell DR. Insulin-like growth factor-binding protein-3 binds fibrinogen and fibrin. J Biol Chem 1999;274:30215–30221.
   PubMed Web of Science ®Google Scholar
• Galiano R, Zhao LL, Clemmons DR, Roth SI, Lin X, Mustoe TA. Interaction between the insulin-like growth factor family and the integrin receptor family in tissue repair processes. Evidence in a rabbit ear dermal ulcer model. J Clin Invest 1996;98:2462–2468.
   PubMed Web of Science ®Google Scholar
• Martino MM, Briquez PS, Ranga A, Lutolf MP, Hubbell JA. Heparin-binding domain of fibrin(ogen) binds growth factors and promotes tissue repair when incorporated within a synthetic matrix. Proc Natl Acad Sci USA 2013;110:4563–4568.
   PubMed Web of Science ®Google Scholar
• Gligorijević N, Nedić O. Interaction between fibrinogen and insulin-like growth factor-binding protein-1 in human plasma under physiologic conditions. Biochemistry Moscow 2016;81:135–140.
   Google Scholar
• Lang CH, Vary TC, Frost RA. Acute in vivo elevation of insulin-like growth factor (IGF) binding protein-1 decreases plasma free IGF-I and muscle protein synthesis. Endocrinology 2003;144:3922–3933.
   PubMed Web of Science ®Google Scholar
• Rajpathak SN, Gunter MJ, Wylie-Rosett J, Ho GYF, Kaplan RC, Muzumdar R, et al. The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes. Diabetes Metab Res Rev 2009;25:3–12.
   PubMed Web of Science ®Google Scholar
• Katz LEL, DeLeón DD, Zhao H, Jawad AF. Free and total insulin-like growth factor (IGF)-I levels decline during fasting: relationships with insulin and IGF-binding protein-1. J Clin Endocrinol Metab 2002;87:2978–2983.
   PubMed Web of Science ®Google Scholar
• Lewitt MS, Denyer GS, Cooney GJ, Baxter RC. Insulin-like growth factor-binding protein-1 modulates blood glucose levels. Endocrinology 1991;129:2254–2256.
   PubMed Web of Science ®Google Scholar
• Cohn EJ, Strong LE, Hughes WL, Mulford DJ, Ashworth JN, Melin M, Taylor HL. Preparation and properties of serum and plasma proteins. IV. A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluids. J Am Chem Soc 1946;68:459–475.
   PubMed Web of Science ®Google Scholar
• Svensson J, Bergman AC, Adamson U, Blombäck M, Wallén H, Jörneskog G. Acetylation and glycation of fibrinogen in vitro occur at specific lysine residues in a concentration dependent manner: a mass spectrometric and isotope labeling study. Biochem Biophys Res Commun 2012;421:335342.
   Web of Science ®Google Scholar
• Xu YJ, Qiang M, Zhang JL, Liu Y, He RQ. Reactive carbonyl compounds (RCCs) cause aggregation and dysfunction of fibrinogen. Protein Cell 2012;3:627–640.
   PubMed Web of Science ®Google Scholar
• Liang JN, Chylack LT. Spectroscopic study on the effects of nonenzymatic glycation in human α-crystallin. Invest Ophthalmol Vis 1987;28:790–794.
   PubMed Web of Science ®Google Scholar
• Shipanova IN, Glomb MA, Nagaraj RH. Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct. Arch Biochem Biophys 1997;344:29–36.
   PubMed Web of Science ®Google Scholar
• Campbell PG, Novak JF. Involvement of the plasmin system in dissociation of the insulin-like growth factor-binding protein complex. Endocrinology 1992;130:1401–1412.
   PubMed Web of Science ®Google Scholar
• Kolev K, Tenekedjiev K, Ajtai K, Kovalszky I, Gombás J, Váradi B, Machovich R. Myosin: a noncovalent stabilizer of fibrin in the process of clot dissolution. Blood 2003;101:4380–4386.
   PubMed Web of Science ®Google Scholar
• Tennent GA, Brennan SO, Stangou AJ, O’Grady J, Hawkins PN, Pepys MB. Human plasma fibrinogen is synthesized in the liver. Blood 2007;109:1971–1974.
   PubMed Web of Science ®Google Scholar
• Awasthi S, Arul Murugan N, Saraswathi NT. Advanced glycation end products modulate structure and drug binding properties of albumin. Mol Pharm 2015;12:3312–3322.
   PubMed Web of Science ®Google Scholar
• Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4–14.
   PubMed Web of Science ®Google Scholar
• Heald AH, Siddals KW, Fraser W, Taylor W, Kaushal K, Morris J, et al. Low circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) are closely associated with the presence of macrovascular disease and hypertension in type 2 diabetes. Diabetes 2002;51:2629–2636.
   PubMed Web of Science ®Google Scholar
• Westwood M, Gibson JM, White A. Purification and characterization of the insulin-like growth factor-binding protein-1 phosphoform found in normal plasma. Endocrinology 1997;138:1130–1136.
   PubMed Web of Science ®Google Scholar
• Wheatcroft SB, Kearney MT. IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis. Trends Endocrinol Metab 2009;20:153–162.
   PubMed Web of Science ®Google Scholar
• Petersson U, Östgren CJ, Brudin L, Brismar K, Nilsson PM. Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the Söderåkra cardiovascular risk factor study. Diabetes Metab 2009;35:198–205.
   PubMed Web of Science ®Google Scholar
• Rajpathak SN, He M, Sun Q, Kaplan RC, Muzumdar R, Rohan TE, et al. Insulin-like growth factor axis and risk of type 2 diabetes in women. Diabetes 2012;61:2248–2254.
   PubMed Web of Science ®Google Scholar
• Tiwari BK, Pandey KB, Abidi AB, Rizvi SI. Markers of oxidative stress during diabetes mellitus. J Biomark 2013;2013:378790.
   PubMedGoogle Scholar
• Hisalkar PJ, Patne AB, Karnik AC, Fawade MM, Mumbare SS. Ferric reducing ability of plasma with lipid peroxidation in type 2 diabetes. Int J Pharm Bio Sci 2012;2:53–56.
   Google Scholar
• Lodovici M, Giovannelli L, Pitozzi V, Bigagli E, Bardini G, Rotella CM. Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control. Mutat Res 2008;638:98–102.
   PubMed Web of Science ®Google Scholar
• Kalapos MP. Where does plasma methylglyoxal originate from? Diabetes Res Clin Pract 2013;99:260–271.
   PubMed Web of Science ®Google Scholar
• Suh KS, Choi EM, Rhee SY, Kim YS. Methylglyoxal induces oxidative stress and mitochondrial dysfunction in osteoblastic MC3T3-E1 cells. Free Radic Res 2014;48:206–217.
   PubMed Web of Science ®Google Scholar
• Lund T, Svindland A, Pepaj M, Jensen A-B, Berg JP, Kilhovd B, Hanssen KF. Fibrin(ogen) may be an important target for methylglyoxal-derived AGE modification in elastic arteries of humans. Diab Vasc Dis Res 2011;8:284–294.
   PubMed Web of Science ®Google Scholar
• Austin GE, Mullins RH, Morin LG. Non-enzymic glycation of individual plasma proteins in normoglycemic and hyperglycemic patients. Clin Chem 1987;33:2220–2224.
   PubMed Web of Science ®Google Scholar
• Kielmas M, Szewczuk Z, Stefanowicz P. A study on human serum albumin influence on glycation of fibrinogen. Biochem Biophys Res Commun 2013;439:78–83.
   PubMed Web of Science ®Google Scholar
• McLellan AC, Phillips SA, Thornalley PJ. The assay of methylglyoxal in biological systems by derivatization with 1,2-diamino-4,5-dimethoxybenzene. Anal Biochem 1992;206:17–23.
   PubMed Web of Science ®Google Scholar
• Lo TWC, Westwood ME, McLellan AC, Selwood T, Thornalley PJ. Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin. J Biol Chem 1994;269:32299–32305.
   PubMed Web of Science ®Google Scholar
• Tsuboi R, Shi CM, Sato C, Cox GN, Ogawa H. Co-administration of insulin-like growth factor (IGF)-I and IGF-binding protein-1 stimulates wound healing in animal models. J Invest Dermatol 1995;104:199–203.
   PubMed Web of Science ®Google Scholar
• Podolnikova NP, Yakubenko VP, Volkov GL, Plow EF, Ugarova TP. Identification of a novel binding site for platelet integrins alpha IIb beta 3 (GPIIbIIIa) and alpha 5 beta 1 in the gamma C-domain of fibrinogen. J Biol Chem 2003;278:32251–32258.
   PubMed Web of Science ®Google Scholar
• Ferreiro JL, Gómez-Hospital JA, Angiolillo DJ. Platelet abnormalities in diabetes mellitus. Diabetes Vasc Dis Re 2010;20:1–9.
   Google Scholar
• Schneider DJ. Factors contributing to increased platelet reactivity in people with diabetes. Diabetes Care 2009;32:525–527.
   PubMed Web of Science ®Google Scholar